RxDoctor Payments Data

Daniel Galvin, DO

Surgical Critical Care · East Meadow, NYNPI 1780649343

Payments from drug & device makers

$270in general payments, 2019–2025

Across 12 payments — averaging $22.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$77
  • Smith+Nephew$69
  • Acell, Inc.$31
  • KARL Storz Endoscopy-america$27
  • AstraZeneca$27
  • Davol Inc.$23
  • plus $16 from 1 others

What the payments were for

  • Food & beverage$24390%
  • Education$2710%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$270 in reported general payments places this provider in the 25th percentile of 118 surgical critical care providers in New York.

See all surgical critical care providers in New York

Medicare billing

Part B allowed, 2024
$144,982
Medicare patients
404
Services billed
812

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl31$96

Paid to pharmacies, not to this prescriber.

Other surgical critical care in East Meadow

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →